To determine the impact of inhibition of tumor cell-derived CSF-1 inhibition on the levels of VEGF-A expression in TMEM doorway macrophages in vivo, we stained the tumors for VEGF-A, F4/80 to identify macrophages, and endomucin. The gene discussed is VEGFA; the disease is neoplasm.